|

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2023-05-25
Est. completion2025-09-11
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06833632

Summary

The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* obtaining voluntary written informed consent
* diagnosis of NSCLC
* clinical stage I-IIA cN0
* Candidates for surgical resection

Exclusion Criteria:

* Pregnancy
* Induction therapy for pulmonary neoplasia
* Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery
* Any previous surgery for lung cancer
* Patients with other active neoplasms
* Infiltration of the chest wall

Conditions3

CancerLung CancerNon Small Cell Lung Cancer

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.